We are live on ! Find out more
MAC

Mason & Associates (California) Portfolio holdings

AUM $619M
1-Year Est. Return 29.44%
This Fund
S&P 500
This Quarter Est. Return
+10.29%
1 Year Est. Return
+29.44%
3 Year Est. Return
+68.54%
5 Year Est. Return
10 Year Est. Return
AUM
$433M
AUM Growth
+$30.8M
Cap. Flow
-$3.54M
Cap. Flow %
-0.82%
Top 10 Hldgs %
56.68%
Holding
122
New
9
Increased
40
Reduced
35
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 8.85%
2 Financials 3.9%
3 Consumer Discretionary 2.47%
4 Communication Services 1.96%
5 Healthcare 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
101
McDonald's
MCD
$194B
$294K 0.07%
1,006
CRSP icon
102
CRISPR Therapeutics
CRSP
$5.23B
$287K 0.07%
5,900
IWY icon
103
iShares Russell Top 200 Growth ETF
IWY
$16.4B
$285K 0.07%
1,157
+4
+0.3% +$890
JNJ icon
104
Johnson & Johnson
JNJ
$626B
$275K 0.06%
1,801
XSOE icon
105
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.09B
$274K 0.06%
7,942
ITA icon
106
iShares US Aerospace & Defense ETF
ITA
$15B
$268K 0.06%
+1,420
New +$236K
IHF icon
107
iShares US Healthcare Providers ETF
IHF
$1.25B
$267K 0.06%
5,485
SUSA icon
108
iShares ESG Optimized MSCI USA ETF
SUSA
$4.16B
$256K 0.06%
2,020
BX icon
109
Blackstone
BX
$118B
$240K 0.06%
1,602
-60
-4% -$8.24K
FCNCA icon
110
First Citizens BancShares
FCNCA
$25.4B
$237K 0.05%
121
DAL icon
111
Delta Air Lines
DAL
$59.5B
$236K 0.05%
4,798
-290
-6% -$13.3K
ISRG icon
112
Intuitive Surgical
ISRG
$142B
$236K 0.05%
434
-28
-6% -$14.6K
IWP icon
113
iShares Russell Mid-Cap Growth ETF
IWP
$20.8B
$234K 0.05%
+1,685
New +$213K
EW icon
114
Edwards Lifesciences
EW
$54B
$226K 0.05%
2,890
-92
-3% -$6.86K
CRBG icon
115
Corebridge Financial
CRBG
$14.9B
$223K 0.05%
+6,278
New +$195K
PWV icon
116
Invesco Large Cap Value ETF
PWV
$1.78B
$215K 0.05%
3,460
LOW icon
117
Lowe's Companies
LOW
$124B
$212K 0.05%
957
-49
-5% -$10.9K
SO icon
118
Southern Company
SO
$106B
$203K 0.05%
2,211
SRPT icon
119
Sarepta Therapeutics
SRPT
$1.92B
$191K 0.04%
+11,170
New +$477K
RXRX icon
120
Recursion Pharmaceuticals
RXRX
$1.8B
$168K 0.04%
33,165
IQLT icon
121
iShares MSCI Intl Quality Factor ETF
IQLT
$14.2B
-296,491
Closed -$11.8M
SPEM icon
122
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.6B
-136,894
Closed -$5.39M

Similar funds

Mason & Associates (California)'s Q2 2025 Portfolio in Review

As of Q2 2025, Mason & Associates (California) held 122 positions worth $433M, up 7.7% from $402M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Mason & Associates (California)'s Q2 2025 filing shows 9 new, 40 increased, 35 reduced and 2 closed positions. Its largest new stake was Columbia Research Enhanced Core ETF: 1,029,239 shares worth $37.9M. The largest sale was Dimensional US Equity ETF, an estimated $34.5M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Mason & Associates (California)'s largest Q2 2025 buy was Columbia Research Enhanced Core ETF: 1,029,239 shares worth $37.9M.
  • Mason & Associates (California) added most to Meta Platforms (Facebook) in Q2 2025, an estimated $892K increase.
  • Mason & Associates (California)'s biggest Q2 2025 reduction was Dimensional US Equity ETF, cutting an estimated $34.5M.
  • Mason & Associates (California) fully exited iShares MSCI Intl Quality Factor ETF in Q2 2025, selling an estimated $11.8M.
  • Mason & Associates (California)'s ten largest holdings make up 57% of its $433M portfolio in Q2 2025.
  • Mason & Associates (California) opened 9 new positions and closed 2 in Q2 2025.
  • Mason & Associates (California)'s portfolio value rose 7.7% quarter-over-quarter to $433M.

Based on Mason & Associates (California)'s 13F filing for Q2 2025, filed 31 Jul 2025.